Daily Archives: October 29, 2020

Study looks into Dito-Chinatel risks

SYDNEY, Oct. 29, 2020 (GLOBE NEWSWIRE) — A study into the new telecommunications operator in the Philippines, Dito Telecommunity, raised serious concerns about cybersecurity, citizens’ privacy and national interests due to the fact that Dito’s 40% non-Philippine partner China Telecom reports directly to the Central People’s Government in China. The report, entitled “A Study Into The

Sorman·Attali·Anholt “Seoul has shown ‘Safe City’ capabilities in the COVID-19 era” reports Republic of Korea news agency Newsis

‘Seoul Brand Global Forum’ was held at ‘Seoul ON’ studio located in Jung-Gu, Seoul on October 28th. Lee Young-Hwan = ‘Seoul Brand Global Forum’ was held at ‘Seoul ON’ studio located in Jung-Gu, Seoul on October 28th. An introductory video is coming out showing session 1 speaker Simon Anholt, founder of the National Brand Concept,

PMTA Verified Launches PMTAFiled.com

Online Resource for Real-Time PMTA Alerts and Updates Miami, FLA, Oct. 29, 2020 (GLOBE NEWSWIRE) — PMTA Verified announces the launch of PMTAFiled.com; the only independent verified online resource for real-time PMTA alerts and updates. Founded by a Board-Certified Emergency Room Physician driven to provide his patients and community up-to-date, unbiased, comprehensive product status information

Sinch announces Conversation API enabling businesses and technology platforms to deliver seamless omni-channel engagement with consumers anywhere in the world

Seattle, WA and Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH Sinch AB (publ), a global leader in cloud communications for mobile customer engagement, today announced Conversation API, a robust omnichannel communication product that empowers businesses and technology platforms to seamlessly engage with consumers in any part of the world. Conversation API leads to improved business outcomes

Sanofi Q3 2020 business EPS(1) growth of 8.8% at CER

Sanofi Q3 2020 business EPS(1) growth of 8.8% at CER Q3 2020 sales growth(2) driven by strong Dupixent® and flu vaccines demand. Net sales were €9,479 million, up 5.7%(2) at CER and down 0.2% on a reported basis. Specialty Care sales grew 23.8%, driven by strong Dupixent® performance (+68.6% to €918 million) and growth in